(Q39728479)

English

A novel therapeutic combination for neuroblastoma: the vascular endothelial growth factor receptor/epidermal growth factor receptor/rearranged during transfection inhibitor vandetanib with 13-cis-retinoic acid

scientific article published on May 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

14 September 2017

A novel therapeutic combination for neuroblastoma: the vascular endothelial growth factor receptor/epidermal growth factor receptor/rearranged during transfection inhibitor vandetanib with 13-cis-retinoic acid (English)

1 reference

Europe PubMed Central

14 September 2017

0 references

1 reference

based on heuristic

inferred from title

Patrick A Zweidler-McKay

7

1 reference

Europe PubMed Central

14 September 2017

6

object named as

John V Heymach

1 reference

Europe PubMed Central

14 September 2017

author name string

Peter E Zage

1

1 reference

Europe PubMed Central

14 September 2017

Lizhi Zeng

2

1 reference

Europe PubMed Central

14 September 2017

Shana Palla

3

1 reference

Europe PubMed Central

14 September 2017

Wendy Fang

4

1 reference

Europe PubMed Central

14 September 2017

Monique B Nilsson

5

1 reference

Europe PubMed Central

14 September 2017

language of work or name

0 references

publication date

1 May 2010

1 reference

Europe PubMed Central

14 September 2017

number of pages

11

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

14 September 2017

116

1 reference

Europe PubMed Central

14 September 2017

10

1 reference

Europe PubMed Central

14 September 2017

2465-2475

1 reference

Europe PubMed Central

14 September 2017

Neuroblastoma in a transgenic mouse carrying a metallothionein/ret fusion gene

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25017

21 January 2018

Multivariate analysis of risk factors in stage 4 neuroblastoma patients over the age of one year treated with megatherapy and stem-cell transplantation: a report from the European Bone Marrow Transplantation Solid Tumor Registry.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25017

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: a children's oncology group study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25017

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcomes of the POG 9340/9341/9342 trials for children with high-risk neuroblastoma: a report from the Children's Oncology Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25017

7 January 2021

based on heuristic

inferred from DOI database lookup

Pilot study of topotecan and high-dose cyclophosphamide for resistant pediatric solid tumors.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25017

7 January 2021

based on heuristic

inferred from DOI database lookup

Sequential treatment of SH-SY5Y cells with retinoic acid and brain-derived neurotrophic factor gives rise to fully differentiated, neurotrophic factor-dependent, human neuron-like cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25017

7 January 2021

based on heuristic

inferred from DOI database lookup

Retinoic acid-induced apoptosis of the CHP134 neuroblastoma cell line is associated with nuclear accumulation of p53 and is rescued by the GDNF/Ret signal

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25017

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased epidermal growth factor receptor in multidrug-resistant human neuroblastoma cells.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25017

7 January 2021

based on heuristic

inferred from DOI database lookup

Proliferation of human neuroblastomas mediated by the epidermal growth factor receptor

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25017

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of vascular endothelial growth factor (VEGF) and VEGF receptors in human neuroblastomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25017

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of vascular endothelial growth factor (VEGF) and its receptors in human neuroblastoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25017

7 January 2021

based on heuristic

inferred from DOI database lookup

Upregulation of vascular endothelial growth factor receptors is associated with advanced neuroblastoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25017

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of the ret proto-oncogene product in human normal and neoplastic tissues of neural crest origin.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25017

7 January 2021

based on heuristic

inferred from DOI database lookup

ZD6474--a novel inhibitor of VEGFR and EGFR tyrosine kinase activity

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25017

7 January 2021

based on heuristic

inferred from DOI database lookup

Vandetanib versus gefitinib in patients with advanced non-small-cell lung cancer: results from a two-part, double-blind, randomized phase ii study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25017

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized phase II study of vandetanib alone or with paclitaxel and carboplatin as first-line treatment for advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25017

7 January 2021

based on heuristic

inferred from DOI database lookup

Potent antitumor effects of ZD6474 on neuroblastoma via dual targeting of tumor cells and tumor endothelium.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25017

7 January 2021

based on heuristic

inferred from DOI database lookup

The emerging role of retinoids and retinoic acid metabolism blocking agents in the treatment of cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25017

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of retinoic acid (RA) on the growth and phenotypic expression of several human neuroblastoma cell lines

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25017

7 January 2021

based on heuristic

inferred from DOI database lookup

Decreased expression of N-myc precedes retinoic acid-induced morphological differentiation of human neuroblastoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25017

7 January 2021

based on heuristic

inferred from DOI database lookup

The RET oncogene is a critical component of transcriptional programs associated with retinoic acid-induced differentiation in neuroblastoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25017

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction of RET Proto-Oncogene Expression in Neuroblastoma Cells Precedes Neuronal Differentiation and Is Not Mediated by Protein Synthesis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25017

7 January 2021

based on heuristic

inferred from DOI database lookup

The anti-VEGF antibody bevacizumab potently reduces the growth rate of high-risk neuroblastoma xenografts

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25017

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical evaluation of ZD6474, an orally active inhibitor of VEGF and EGF receptor signaling, in patients with solid, malignant tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25017

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I trial of 13-cis-retinoic acid in children with neuroblastoma following bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25017

7 January 2021

based on heuristic

inferred from DOI database lookup

Steady state pharmacokinetics of oral treatment with 13-cis-retinoic acid or all-trans-retinoic acid in male and female adult rats.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25017

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.25017

1 reference

Europe PubMed Central

14 September 2017

1 reference

Europe PubMed Central

14 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39728479&oldid=2089175525"